Literature DB >> 3119013

Asymptomatic hyperuricaemia.

J T Scott.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3119013      PMCID: PMC1246150          DOI: 10.1136/bmj.294.6578.987

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Some observations on 520 gouty patients.

Authors:  W C KUZELL; R W SCHAFFARZICK; W E NAUGLER; P KOETS; E A MANKLE; B BROWN; B CHAMPLIN
Journal:  J Chronic Dis       Date:  1955-12

2.  Renal outcomes of gout and hyperuricemia.

Authors:  W J Fessel
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

3.  Hyperuricemia in health and disease.

Authors:  W J Fessel
Journal:  Semin Arthritis Rheum       Date:  1972       Impact factor: 5.532

4.  Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.

Authors:  J Auböck; P Fritsch
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-29

5.  The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality.

Authors:  J Z Singer; S L Wallace
Journal:  Arthritis Rheum       Date:  1986-01

6.  Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.

Authors:  T F Yü; L Berger
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

7.  Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study.

Authors:  F N Brand; D L McGee; W B Kannel; J Stokes; W P Castelli
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

  7 in total
  2 in total

Review 1.  Interventions in chronic renal failure.

Authors:  J R Curtis
Journal:  BMJ       Date:  1990-09-29

2.  Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

Authors:  R O Day; J O Miners; D J Birkett; A Whitehead; D Naidoo; J Hayes; E Savdie
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.